UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Completed · Phase 1
Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of UCN-01 and cisplatin in treating patients who have advanced or metastatic solid tumors.
Key facts
- Study ID
- NCT00006464
- Run by
- City of Hope Medical Center
- Starts
- 2001-03-01
- Expected to finish
- 2008-06-01
- Last updated by the study team
- 2010-01-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
- City of Hope Medical Group — Pasadena, California, United States
- University of California Davis Cancer Center — Sacramento, California, United States
- Norris Cotton Cancer Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.